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ABSTRACT
Study objective We investigated two peer distribution 
models of HIV self- testing (HIVST) in HIV prevention 
demand creation compared with trained young 
community members (peer navigators).
Methods We used restricted randomisation to allocate 
24 peer navigator pairs (clusters) in KwaZulu- Natal 
1:1:1: (1) standard of care (SOC): peer navigators 
distributed clinic referrals, pre- exposure prophylaxis 
(PrEP) and antiretroviral therapy (ART) information to 
18–30 year olds. (2) peer navigator direct distribution 
(PND): Peer navigators distributed HIVST packs (SOC 
plus two OraQuick HIVST kits) (3) incentivised peer 
networks (IPN): peer navigators recruited young 
community members (seeds) to distribute up to five 
HIVST packs to 18–30 year olds within their social 
networks. Seeds received 20 Rand (US$1.5) for each 
recipient who distributed further packs. The primary 
outcome was PrEP/ART linkage, defined as screening for 
PrEP/ART eligibility within 90 days of pack distribution 
per peer navigator month (pnm) of outreach, in women 
aged 18–24 (a priority for HIV prevention). Investigators 
and statisticians were blinded to allocation. Analysis was 
intention to treat. Total and unit costs were collected 
prospectively.
Results Between March and December 2019, 4163 
packs (1098 SOC, 1480 PND, 1585 IPN) were distributed 
across 24 clusters. During 144 pnm, 272 18–30 year 
olds linked to PrEP/ART (1.9/pnm). Linkage rates for 
18–24- year- old women were lower for IPN (n=26, 0.54/
pnm) than PND (n=45, 0.80/pnm; SOC n=49, 0.85/pnm). 
Rate ratios were 0.68 (95% CI 0.28 to 1.66) for IPN 
versus PND, 0.64 (95% CI 0.26 to 1.62) for IPN versus 
SOC and 0.95 (95% CI 0.38 to 2.36) for PND versus 
SOC. In 18–30 year olds, PND had significantly more 
linkages than IPN (2.11 vs 0.88/pnm, RR 0.42, 95% CI 
0.18 to 0.98). Cost per pack distributed was cheapest 
for IPN (US$36) c.f. SOC (US$64). Cost per person linked 
to PrEP/ART was cheaper in both peer navigator arms 
compared with IPN.
Discussion HIVST did not increase demand for PrEP/
ART. Incentivised social network distribution reached 
large numbers with HIVST but resulted in fewer linkages 
compared with PrEP/ART promotion by peer navigators.
Trial registration number NCT03751826.
Key questions
What is known?
 ► Randomised controlled trials in Southern Africa have 
shown that HIV self- testing (HIVST) increases the 
knowledge of HIV status in adolescents and men and 
can improve linkage to HIV care and voluntary male 
medical circumcision when delivered with enablers 
such as financial incentives.
What are the new findings?
 ► HIVST rapidly reached men and women aged 18–30 
in rural KwaZulu- Natal. However, HIVST did not cre-
ate demand for biomedical HIV prevention, including 
Pre- Exposure Prophylaxis, compared with peer- led 
community- based support.
What do the new findings imply?
 ► These findings suggest that incentivised peer net-
work models may reach young people with HIV test-
ing. However, it would need to be provided alongside 
trained peer- led activities to effectively attract and 
engage young people into novel biomedical HIV 
prevention.
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INTRODUCTION
In 2019, South Africa (SA) had 7.5 million people living 
with HIV (PLHIV) with an estimated 200 000 new infec-
tions, mainly in adolescents girls and young women1 
despite highly efficacious biomedical HIV prevention 
options, including pre- exposure prophylaxis (PrEP), 
voluntary medical male circumcision (VMMC) and 
HIV treatment with antiretroviral therapy (ART). ART 
improves health and eliminates onward transmission 
from PLHIV once sustained viral load suppression is 
achieved.2 3 PrEP can reduce HIV acquisition by up to 
90%, and VMMC reduces HIV acquisition in men by 
60%.4 5
Adolescents and youth, although highly vulnerable 
to HIV, have numerous structural and social barriers to 
taking up both HIV testing and subsequent HIV preven-
tion services.6–11 HIV self- testing (HIVST), delivered as 
simple oral fluid or blood- based self- test kits, provides 
a discreet and convenient way for individuals to collect 
their own specimens and interpret their own results in 
private, overcoming testing barriers.12–14 HIVST can 
increase uptake of HIV testing among high- risk popu-
lations including young people,15–18 but the extent to 
which HIVST can create demand for subsequent HIV 
prevention services remains unclear.19 20
Realising the potential of biomedical prevention 
methods, including PrEP, to alter the course of the HIV 
epidemic in SA will require high coverage among those 
at risk, including adolescent girls and young women.21 22 
This was particularly the case in KwaZulu- Natal (KZN), 
where, prior to this study, annual HIV incidence was 
8% among women aged 20–24% and 5% among 
women aged 15–19.23 24 Meanwhile, we and others 
had shown that peer- led community- based approaches 
foster social networks and norms that endorse HIV 
prevention, particularly among adolescents and young 
people.10 25–29
We hypothesised that distribution of oral HIVST kits 
could enhance peer- led community- based health promo-
tion strategies to mobilise demand for biomedical HIV 
prevention by empowering young people to test them-
selves in private and evaluate their candidacy for HIV care 
and prevention.7 12 17 30 31 We also hypothesised that mobil-
ising social networks to distribute HIVST using incentiv-
ised peer- led methods (respondent- driven sampling) 
would extend the reach of HIVST and demand for PrEP 
among young people who were most at- risk compared 
with direct distribution.19 32 33
The aim of this cluster- randomised controlled trial 
(cRCT) was to investigate whether HIVST delivered 
by peers, either directly or through incentivised social 
networks, would increase demand for PrEP/ART among 
adolescent girls and young women aged 18–24 years and 
all young people (aged 18–30) in a rural setting with a 
high burden of HIV in KZN, SA.
METHODS
Study design, setting and participants
The trial design has been described in detail else-
where.34 Briefly, between March and December 2019, 
we conducted a three- arm cRCT comparing two models 
of peer delivery of HIVST (incentivised peer networks 
(IPN) and direct distribution by trained area- based peer 
navigators) with standard of care (SOC, referral by peer 
navigators to HIV testing, prevention and care services) 
for increasing the uptake of biomedical HIV prevention 
(PrEP) or ART among young women (18–24) and all 
young people (aged 18–30).
The trial was conducted in the Africa Health Research 
Institute (AHRI) demographic surveillance area in uMkh-
anyakude a poor and rural district of KZN.35 At the time 
of the trial, HIV incidence was high among young men 
and women (peaking at 8% per annum among women 
aged 20–24% and 4% per annum in men aged 25–29) and 
above the WHO threshold of eligibility for PrEP.23 24 Clin-
ical care, including PrEP initiation, was provided through 
nurse- led adolescent and youth friendly study clinics. 
These included two accessible primary health clinics and 
mobile clinics that visit fixed sites across the study area. 
AHRI data collection clerks and nurses embedded within 
the 11 public health clinics serving this community also 
provided care to study participants.
The unit of randomisation (clusters) was 24 pairs of 
peer navigators working in 24 discrete areas (based on 
administrative divisions) of the surveillance area. Peer 
navigators aged 18–30 years (men and women) who had 
completed secondary schooling were recruited through 
local municipal and traditional leaders. The peer navi-
gators underwent a 20- week training programme, which 
covered youth development, HIV and sexual health infor-
mation, accredited HIV counselling and testing course, 
confidentiality, ethics and research methods, study proce-
dures and HIVST. Competence was assessed using written 
and oral assessments to select 57 eligible peer navigators 
(24 pairs of area- based peer navigators and nine floating 
peer navigators (ie, on stand- by to support the arm they 
were randomised to)).30
Recruitment was community based. An estimated 
12 000 young people (aged 18–30 years) residing in the 
24 cluster areas were eligible to participate if able and 
willing to provide written informed consent, and not 
already taking ART. Young people were recruited by peer 
navigators who approached young people, in commu-
nity settings, near schools and households, within each 
cluster to provide information and promote the study. 
Participants completed a brief electronic questionnaire 
and received a barcoded and colour co- ordinated pack 
that included arm- specific material and referral slips for 
clinical services.
Outcome ascertainment was facility based. Trained 
clinical research assistants screened all attendees of the 
three study clinics (mobile and fixed) and 11 public facil-
ities serving the study catchment population for outcome 
eligibility (aged 18–30 and referred from 1 of the 24 
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study clusters). A screening questionnaire was adminis-
tered to all consenting youth aged 18–30 years, with a 
request to scan their unique barcoded identifier for the 
clinic referral slip.
Everyone attending clinical services was offered HIV 
counselling and confirmatory HIV testing, immediate 
initiation of ART if positive or offer of PrEP (daily 
generic tenofovir disoproxil fumerate and emtricitabine) 
if HIV negative and eligible, according to South African 
National guidelines. Everyone received sexual health 
promotion, contraception and condoms. HIV- negative 
men were counselled on the benefits of VMMC and 
referred.
Intervention
In all three arms, peer navigators promoted sexual health 
and the benefits of HIV testing PrEP and ART. In both 
intervention arms, they also demonstrated how to use the 
HIVST kit. All participants were asked to complete a brief 
check of their understanding of the information provided 
to them. Peer navigators recorded date of recruitment, 
participant’s age, area of residence and optional personal 
identifiers (name, national identification number and 
mobile phone number) and scanned the bar- coded 
packs for individual use (and in the case of the IPN arm 
for distribution). The survey took approximately 5 min to 
complete and was available in both English and isiZulu. 
Each peer navigator worked part time and recruitment 
continued for 6 months.
Standard of care
n=8 pairs of peer navigators approached young people 
aged 18–30 years and distributed uniquely barcoded 
yellow packs that included condoms and linkage infor-
mation (clinic referral slips and information leaflets 
about HIV and PrEP).
Peer navigator direct distribution of HIVST
n=8 pairs of peer navigators approached young people 
aged 18–30 years and distributed uniquely barcoded blue 
HIVST packs that included SOC information and two 
HIVST kits (OraQuick HIV self- test kit, OraSure Tech-
nologies) with information sheets in English and IsiZulu.
Incentivised network distribution of HIVST
n=8 pairs of peer navigators used a modified respondent- 
driven sampling approach to distribute uniquely 
barcoded pink HIVST packs, which included SOC infor-
mation and two HIVST kits. Each peer navigator recruited 
five 18–24- year- old female ‘seeds’ from their area. Seeds 
were then given up to five uniquely numbered incentiv-
ised recruitment coupons and pink HIVST packs to pass 
onto members of their social network. They were asked 
to distribute coupons and packs, demonstrate HIVST 
kit use and promote PrEP/ART to women aged 18–24 
years preferentially but not exclusively and to avoid distri-
bution of HIVST to those under the age of 18 or over 
the age of 30 years. When coupons were returned, the 
original individual (seed) who handed out the coupon 
received a sum of SAR20 (US$1.5) in mobile phone data. 
Each individual who returned with one of the coupons 
to a peer navigator (respondent) underwent the same 
procedure as the seeds, that is, they were given up to five 
uniquely numbered incentivised recruitment coupons 
and pink HIVST packs to pass onto members of their 
social network. This process continued for 6 months. For 
more details, see online supplemental figure 1.
Randomisation, allocation and blinding
Prior to randomisation, pairs of peer navigators were 
assigned to the 24 areas they resided in. The remaining 
nine peer navigators were designated floating peers. 
Randomisation was conducted by the statistician 
(Thandiwe Nondumiso Mthiyani (TNM)) on the 17 
January 2019. Randomisation was restricted to ensure 
that (1) all arms had at least one and no more than 
three urban areas, at least one and no more than four 
peri urban areas and at least two and no more than six 
urban areas; (2) local prevalence of HIV testing and 
uptake of Determined, Resiliant, Empowered, AIDS free. 
Mentored and Safe (DREAMS) combination HIV preven-
tion were both within two SD of the average across the 
study area.36 37 The study statistician (TMN) generated 
a list of 100 000 randomisations; after the restrictions 
described above, 47 924 remained. The final groupings 
of peer navigators into three arms were completed using 
statistical software, into three groups of 8 pairs and three 
floating peer navigators (A, B and C). Allocation of peer 
navigator groupings to the interventions was completed 
at a public ceremony on 23 January 2019, where a desig-
nated group representative picked their study arm from 
a concealed box in the presence of the other peer naviga-
tors and the social science team.
Although the nature of the study meant that partici-
pants and peer navigators could not be blinded, masking 
of the investigators, statistician and the clinical (nursing) 
team to the allocation arm was maintained until all data 
were captured and cleaned at two time points: once (5 
June 2019) to allow an interim analysis to inform 2019 
WHO HIVST Guidelines and again at study completion 
(26 May 2020).
Outcomes and measurement
The primary outcome was the number of PrEP/ART 
linkage events among women aged 18–24 years per 
peer navigator month (pnm) of outreach work. Linkage 
was defined as attending clinic- based PrEP eligibility 
screening or starting ART (based on HIV status) within 
90 days of receiving a pack.
Linkage events were captured at study clinics and any 
of the 11 primary health clinics through scanning the 
barcode with the unique identifier on the clinic referral 
slip. Participants who reported having been given a 
referral slip that they had not brought with them were 
linked back to a peer navigator team using an algorithm 
based on reported colour of referral slip, pack content, 
residential address and identity of the peer navigator who 
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recruited them. Furthermore, we matched their name, 
ID and telephone number (if available) in the eligibility 
questionnaire with data collected by peer navigators in 
the field.
Secondary study outcomes were (a) the total number 
of linkages among all participants (men and women aged 
18–30) per pnm and (b) the total number of linkages 
(men and women aged 18–30) per 100 packs distributed 
as well as (c) the costs per HIVST distributed and young 
person aged 18–30 linked to care. A qualitative process 
evaluation is reported in a companion paper.38
Analysis and sample size
We calculated the sample size for the primary outcome 
of linkage among women aged 18–24. Based on routine 
data, we estimated that one woman would link per 6 
months of peer navigators’ outreach in SOC, with high 
potential to considerably increase linkage and that a 
substantial impact would be needed to justify the addi-
tional complexity and expense of adding HIVST to the 
peer navigator programme. There were no other data 
on which to base our sample size estimates, as this was 
the first study to address this question. We, therefore, 
assumed that adding HIVST would increase linkage by 
100% to 150%, in which case 8 clusters per arm with 6 
months of follow- up would provide 80% power to detect 
a 100% increase in linkage events with intercluster coef-
ficient of variation (k) 0.25 or a 150% increase with k of 
0.35.
The analysis of primary outcome followed both 
intention- to- treat (ITT) and per- protocol approaches. 
The numerator was the number of young women aged 
18–24 who linked (as defined above) per cluster. In the 
ITT analysis, the denominator was the full follow- up time 
(months) calculated from the date at which the study 
started (15 March 2019) and last date of referrals (15 
September 2019) per cluster. In the per- protocol analysis, 
the denominator was the actual time spent by peer navi-
gators distributing packs in each cluster. The time worked 
by each peer- navigator pair in a cluster was combined to 
get the total time per cluster.
The analysis of secondary outcomes used ITT. For 
the difference in linkage/pnm, the numerator was the 
number of young people aged 18–30 who linked (as 
defined above) per cluster. Differences in linkage per 100 
referral slips distributed, the numerator was the number 
of young people aged 18–30 who linked (as defined 
above) per cluster, and the denominator was the number 
of packs distributed by peer navigator per cluster.
Differences in rate of linkage between incentivised 
HIVST delivery through peer networks and direct distri-
bution of HIVST arms were analysed using cluster- level 
summaries, t- tests and rate ratio. Outcomes in each cluster 
were summarised using rates (expressed as the number 
of linkage events per unit of peer navigator outreach 
time), with each cluster contributing a single rate to the 
analysis. In the analysis, the cluster- level linkage rates 
were log transformed due to non- normal distribution 
and then summarised for each study arm using means. 
Outcomes for both ITT and per- protocol analyses were 
summarised using the same approach. In each pairwise 
comparison, the differences between log cluster means 
were calculated, and t- tests were used to assess statistical 
significance. The cluster- level approach, although less 
statistically efficient than methods based on individual 
level regression, is considered to be more robust when 
there are a relatively small number of clusters.39 To incor-
porate the restriction of randomisation options used, 
we calculated permutation p values for the ITT analyses 
of the primary outcome.40 All analyses were performed 
using STATA V.15 (StataCorp LP, College Station, Texas).
Cost analysis
Costs per pack distributed and young person linked to 
care were calculated using a bottom- up ingredient- based 
costing approach supplemented by a top- down expend-
iture analysis using the study budgets and expenditure 
reports. Capital costs included equipment (laptops for 
nurse and administrator, study phones and tablets for 
peer navigators) and training for the peer navigators 
(staff costs to train and supervise the peer navigators and 
external training). Recurrent costs included personnel 
costs (the peer navigators stipend, calculated per hour of 
work and staff to supervise the peer navigators), supplies 
(packs, health promotion material, referral slips, data 
for tablet connectivity and protective clothing), trans-
port (including delivering packs to peer navigators in 
the field), Oraquick HIVST test kits, RDS incentives and 
other (mobile phone air time). Where costs were shared 
and similar for the three arms, we allocated costs equally 
across the three arms. This did not include the peer navi-
gator costs that were calculated using the actual time they 
spent distributing referral packs. We calculated the unit 
cost per HIVST and referral pack distributed and the cost 
per person aged 18–30 linked to PrEP/ART per arm.
Adverse events
The data were collected with written or witnessed 
informed consent of participants prior to being included 
in the study.
Provision of both HIVST and PrEP for high- risk indi-
viduals was already international and national policy 
within SA at the time of the trial. The independent 
scientific Technical Advisory Group (TAG) of the HIVST 
Africa initiative reviewed safety data and oversaw the trial 
using data reported according to a previously described 
adverse event (AE) reporting system for HIVST that 
included direct and indirect social harms from HIVST 
graded by severity.41 AEs were captured through process 
evaluation, community engagement units and reporting 
via a free hotline number provided on referral slips. Peer 
navigators and clinic staff logged AEs using an incident 
reporting form. Severe AEs were logged with the prin-
cipal investigator for review and likely relationship to 
HIVST and reported to the STAR TAG and Ethics Review 
Boards.
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Patient public engagement
The primary beneficiaries of improving access to 
primary and secondary HIV prevention are adolescents 
and youth. Our patient public engagement continued 
throughout the research process. The study was 
presented to the Community Advisory Board, peer navi-
gators and the District Department of Health, to provide 
input into the relevance and importance of the research 
question and outcome measures, before submission to 
Institutional Review Boards. Community- based partici-
patory research (CBPR) was used to provide youth input 
into the final peer navigator interventions.30 Peer navi-
gators and youth engagement during CBPR informed 
the design of the intervention and inclusion of the two 
different intervention arms, peer navigator distribution 
and social network distribution of the HIVST. Peer navi-
gators witnessed randomisation and assisted in making 
study clinics youth- friendly, identifying the sites for the 
mobile clinics, and designed the information and educa-
tional materials. Peer navigators and young people who 
were engaged in the network distribution of HIVST 
recruited participants in all three arms of the study. The 
process evaluation explored the burden of the inter-
vention, priorities, experiences and preferences of the 
adolescents and young people throughout the trial. 
Results dissemination included peer navigators, youth 
stakeholders, community advisory committee and the 
research community through local and international 
symposia.
RESULTS
Participant flow and recruitment
Twenty- four pairs of area- based peer navigators and 
nine floating peer navigators were randomly assigned to 
three arms (figure 1). Between 13 March 2019 and 14 
September 2019, there were 144 peer navigator working 
months (6 months for each peer navigator pair). All 24 
peer navigator pairs were retained in their originally 
assigned groups and included final analysis of primary 
and secondary outcomes (figure 1).
Baseline data and numbers analysed
Between March 2019 and September 2019, 4163 
referral packs were distributed across the three arms. As 
detailed in methods, packs included information sheets, 
a barcoded referral slip and, in the HIVST arms, two 
HIVST kits. For peer navigator direct distribution (PND) 
and SOC arms, numbers of referral packs directly distrib-
uted were 1480 (35.6%) and 1098 (26.4%), respectively, 
taking up a total of 13 117 and 11 390 hours of peer navi-
gator time (table 1). Peer navigators in the IPN distribu-
tion arm spent less time (5039 hours total) implementing 
the intervention and distributed the highest number of 
referral packs (1585, 38.1% of total). Peer navigators in 
the eight IPN clusters approached n=55 seeds (women 
aged 18–24), this resulted in n=216 incentivised respond-
ents during 6 months and seven recruitment waves. The 
structure of the social networks through which distribu-
tion occurred in the IPN arm is summarised in figure 2.
Figure 1 Consort diagram for cluster RCT of different models of peer- led HIVST distribution on uptake of biomedical HIV 
prevention and care. ART, antiretroviral therapy; HIVST, HIV self- testing; PrEP, pre- exposure prophylaxis; RCT, randomised 
controlled trial.
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As a result of the 144 pnm of work, 120 women aged 
18–24 (0.83/pnm) and 272 (1.89/pnm) men and women 
aged 18–30 were linked to either ART or PrEP assess-
ment (figure 1). Of these, 202 (74.3%) of the 18–30 year 
olds were initiated on PrEP or diagnosed with HIV and 
started on ART. This included 180 who were HIV nega-
tive, eligible and started PrEP.
Linkage to PrEP/ART
Despite the higher number of referral packs distributed, 
fewer women aged 18–24 years linked to PrEP/ART 
through incentivised peer navigator (social) networks 
(n=26, 0.54/pnm, p=0.3) than direct peer navigator arms 
(PND n=45, 0.80/pnm; SOC n=49, 0.85/pnm, p=0.9), 
although not significantly so (table 2A). Adding HIVST 
did not change direct peer navigator linkage (RR 0.95 
95% CI 0.38 to 2.36).
The per- protocol analysis (table 2B) used the numbers 
of hours spent implementing the intervention (distrib-
uting referral packs) as the denominator, rather than 
a fixed number of pnm. The results of this analysis 
suggest that linkage rates per time that peer navigators 
spent distributing HIVST and promoting linkage may be 
higher in the IPN arm (n=0.40 per 100 peer navigator 
hours) compared with the peer navigator arms; 0.21/100 
Table 1 Cluster level distribution of data per arm
Incentivised peer navigator 
(IPN)
Peer navigator distribution 
+HIVST (PND)
Peer navigator no HIVST 
(SOC)
Number of peer navigator pairs per arm 8 8 8
Number of referral packs distributed per 
arm
1585 1480 1098
Mean age of pack recipients per arm 22.0 23.0 22.5
Peer navigator pair months (pnm) of work 
per cluster
6 6 6
Mean number of hours peer navigator pairs 
spent on distributing packs per cluster
629.88 1639.63 1423.75
Mean number of referral packs distributed 
per cluster
198.13 185.00 137.25
Mean number of 18–30 year olds linked/
pnm per cluster
1.04 2.31 2.31
HIVST, HIV self- testing; IPN, incentivised peer network; PND, peer navigator direct distribution; SOC, standard of care.
Figure 2 Incentivised peer navigator distribution chains (n=1585). Arm 1: incentivised peer (social) network packs. n = 55 
female seeds aged 18–24 approached across 8 clusters. n=216 incentivised recruitments distributed n=1585 packages.
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pnh (RR 1.93 95% CI 0.95 to 3.89, p=0.07) and 0.24/100 
pnh (RR 1.66 95% CI 0.75 to 3.69, p=0.2) for PND and 
SOC, respectively.
Table 2C shows that for all young adults aged 18–30, there 
was stronger evidence of lower linkage rates (0.88/pnm) 
for incentivised peer distribution than peer navigator distri-
bution (2.11/pnm, RR 0.42, 95% CI 0.18 to 0.98, p=0.04) 
and SOC (2.07/pnm, RR 0.42 95% CI 0.18 to 1.02, p=0.06). 
Similarly, there was stronger evidence (table 2D) that fewer 
people linked to PrEP/ART per 100 packs distributed in 
the incentivised peer distribution (3.23/100 packs) than 
peer navigator distribution (7.36/100 packs, RR 0.44 
95% CI 0.21 to 0.92, p=0.03) and SOC (9.62/100 packs, RR 
0.34 95% CI 0.14 to 0.78, p=0.01). Adding HIVST did not 
change the rate of direct peer navigator linkage (p=0.5). 
No serious AEs or inadvertent social harms occurred. For 
forest plots of outcome of cRCT: PrEP/ART linkage rate, 
see online supplemental figure 2.
Table 2 Outcome of the cRCT: PrEP/ART linkage rate
A: Primary outcome: intention to treat analysis among women aged 18–24
Number of clients 
linked
Geometric mean linkage 
per peer navigator month 
of working (/pnm) Rate ratio (95% CI) P value* K†
Incentivise peer navigation 26 0.54 0.68 (0.28 to 1.66) 0.40‡ 0.69
Peer navigation direct 45 0.80 1.01
Incentivise peer navigation 26 0.54 0.64 (0.26 to 1.62) 0.30§ 0.69
Standard of care 49 0.85 0.96
Peer navigation direct 45 0.80 0.95 (0.38 to 2.36) 0.90¶ 1.01
Standard of care 49 0.85 0.96
B: Primary outcome: per protocol analysis of linkage among women aged 18–24, accounting for difference in hours spent distributing referral 
packs by arm
Number of clients 
linked
Geometric mean linkage 
per 100 hours of peer 
navigator (/100pnh) Rate ratio (95% CI) P value* K†
Incentivise peer navigation 26 0.40 1.93 (0.95 to 3.89) 0.07 1.31
Peer navigation direct 45 0.21 0.20
Incentivise peer navigation 26 0.40 1.66 (0.75 to 3.69) 0.19 1.31
Standard of care 49 0.24 0.66
Peer navigation direct 45 0.21 0.86 (0.43 to 1.74) 0.66 0.20
Standard of care 49 0.24 0.66
C: Linkage rate among men and women aged 18–30 per peer navigator month of work (ITT)
Number of clients 
linked
Geometric mean linkage 
rate (/pnm) Rate ratio P value* K†
Incentivise peer navigation 50 0.88 0.42 (0.18 to 0.98) 0.04 0.74
Peer navigation direct 111 2.11 0.62
Incentivise peer navigation 50 0.88 0.42 (0.18 to 1.02) 0.06 0.74
Standard of care 111 2.07 0.59
Peer navigation direct 111 2.11 1.02 (0.52 to 2.01) 0.95 0.62
Standard of care 111 2.07 0.59
D: Linkage rate among all men and women aged 18–30 per 100 referral packs distributed
Number of clients 
linked
Geometric mean linkage 
rate (/100 referrals) Rate ratio P value* K†
Incentivise peer navigation 50 3.23 0.44 (0.21 to 0.92) 0.03 0.76
Peer navigation direct 111 7.36 0.60
Incentivise peer navigation 50 3.23 0.34 (0.14 to 0.78) 0.01 0.76
Standard of care 111 9.62 0.95
Peer navigation direct 111 7.36 0.76 (0.35 to 1.68 0.48 0.60
Standard of care 111 9.62 0.95
*P- values calculated from a t- test with a pairwise comparison of the log- transformed cluster- level means.39
†k=intercluster coefficient of variation.
‡Permutation p value 0.33.
§Permutation p value 0.28.
¶Permutation p value 0.89.
ART, antiretroviral therapy; cRCT, cluster- randomised controlled trial; ITT, intention- to- treat; PrEP, pre- exposure prophylaxis.
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Cost-effectiveness results
The average cost of reaching each young person with 
health promotion material (SOC) was less in both HIVST 
arms compared with SOC, reflecting higher numbers 
reached. Cost per kit distributed (two kits per referral 
pack) was US$18 for distribution through IPN compared 
with US$28 per HIVST distributed by peer navigators 
(table 3). On the other hand, the additional cost of 
linking each young person to PrEP/ART compared with 
SOC was US$114 for peer navigator direct HIVST distri-
bution and US$513 for IPN.
DISCUSSION
In this community- based cluster- randomised trial from 
SA, we report the impact of two approaches to peer- based 
HIVST distribution on uptake of biomedical HIV preven-
tion in adolescent girls and young women, comparing the 
HIVST arms against a peer- based SOC arm promoting 
standard HIV testing services. We found that peer- based 
HIVST distribution did not increase demand for PrEP/
ART, despite reaching large numbers of young people. 
Incentivised social network distribution reached large 
numbers of young people with HIVST and health promo-
tion material but resulted in fewer linkages compared 
with PrEP/ART promotion by peer navigators, making 
this one of the first trials to suggest that a direct approach 
by trained peers is effective in mobilising demand for 
biomedical HIV prevention in young people. Although 
incentivised social network models of HIVST distribution 
resulted in fewer linkages compared with direct mobili-
sation, peer navigators spent substantially less time inter-
acting with young people, resulting in the highest linkage 
rates when peer navigator hours of implementation were 
used as the denominator. These findings suggest that IPN 
models may have a place in distributing HIV testing, if 
used alongside trained peer- led activities to attract and 
engage young people with HIV prevention.
We found that oral- based HIVST was an efficient and 
acceptable way to reach young people with HIV testing in 
this rural setting. Peer navigators managed to distribute 
over 6 000 HIVST either directly or through social 
networks over a period of 6 months, potentially reaching 
the majority of the 8000 young people aged 18–30 residing 
in their areas with minimal social harm.38 Our findings 
from rural SA replicate findings from studies elsewhere 
in sub- Saharan Africa that showed that community- based 
distribution of HIVST is an acceptable tool to reach 
young people with HIV testing.14 15 17 18 HIVST has the 
potential to enable young people to explore their candi-
dacy for HIV care and prevention in privacy.7 12
Disappointingly, we did not show that HIVST inde-
pendently mobilised demand for biomedical prevention. 
While knowledge of HIV status is the gateway into the cascade 
of care and prevention, it may not be sufficient to link young 
Table 3 Cost (US$) per pack distributed and young person linked to PrEP/ART per arm
Standard of care Incentivised peer distribution Peer navigator distribution
Capital costs
Equipment US$13 094 US$13 205 US$13 093
Training US$5505 US$5505 US$5505
Total capital costs US$18,5981 US$18 710 US$18 598
Recurrent costs
Personnel costs US$47 277 US$27 227 US$52 729
Incentives paid 0 $273 0
Oraquick test kit 0 $6781 $6444
Other supplies $3015 $3231 $3186
Transport $763 $438 $1173
Other recurrent $104 $396 $181
Total recurrent costs 51 158 $38 345 $63 713
Total cost 69 757 $57 055 $82 311
Outputs
Number of HIVST distributed 0 3170 2960
Number of referral pack distributed 1098 1585 1480




HIVST delivered NA $18 $28
Per referral pack distributed $64 $36 $56
Per young person linked to PrEP/ART $628 $1141 $742
ART, antiretroviral therapy ; HIVST, HIV self- testing; PrEP, pre- exposure prophylaxis.
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people to care and prevention. Previous work from our and 
other settings has highlighted the barriers young people 
face in linking to HIV care and PrEP.7 9–12 22 42 To overcome 
these barriers, we chose to provide PrEP through youth- 
friendly sexual and reproductive health services designed 
to be neutral to client HIV status or gender. However, our 
process evaluation revealed other social barriers to PrEP 
uptake, such as the fear of stigma and discrimination from 
family members, inadvertent disclosure of sexual activity and 
fear of side effects.38 These barriers mirror those described 
in PrEP demonstration projects across SA and suggest that 
HIVST as a tool to mobilise demand for PrEP may need to 
be used alongside other intervention to attract and engage 
young people.22
HIVST could mobilise demand for VMMC in men.19 43 
While all young men who linked to our clinics through the 
trial were referred for VMMC, our study design was not able 
to ascertain whether they did indeed undergo the proce-
dure. Further work is planned to explore whether or not 
exposure to HIVST through the trial was associated with 
uptake of VMMC and to explore this model further.
To our knowledge, our trial is one of the first to 
suggest that peer- led interventions may mobilise demand 
for biomedical HIV prevention in adolescents and 
youth.44–46 There has been growing body of evidence to 
show the effectiveness of community- based HIV care. 
A meta- analysis of community healthcare workers’ role 
in supporting HIV treatment found that it significantly 
improved viral suppression (pooled OR: 1.40 95% CI 
1.06 to 1.86)47 and more recently a multicomponent 
peer–mentor intervention among adolescents living with 
HIV in Zimbabwe showed significant improvements in 
virological suppression over 2 years.48 49
Evidence for similar peer- based interventions to support 
biomedical HIV prevention for young people is, however, 
more limited. A systematic review of reviews on the cascade 
of HIV prevention identified 54 peer- based interventions of 
which the majority was among female sex workers.45 Only 
12 studies focused on young people; these consisted of peer 
education in schools or participatory learning approaches 
to empower young men and women to take greater control 
over their sexual and emotional relationships. The outcome 
in the majority was improvements in knowledge, sexual 
behaviour, condom use or HIV testing, rather than biolog-
ical outcomes or engagement with biomedical interven-
tions.45 Our findings on the acceptability and effectiveness 
of trained peer navigators to enable youth engagement 
with biomedical prevention suggests that area- based trained 
peer navigators are an untapped resource to engage young 
people with biomedical HIV prevention. Trials are ongoing 
to test the effectiveness of HIV serostatus neutral peer 
mentorship to reduce transmissible HIV in adolescents and 
youth in this setting.
Strengths and limitations
The main strength of our study was that our evaluation 
of using oral HIVST to mobilise demand for biomed-
ical HIV prevention used an area- based peer navigator 
intervention that could be feasibly scaled up in similar 
rural settings in high- HIV- incidence areas of sub- Saharan 
Africa. Limitations include much higher intercluster 
variation than expected, reducing power for our primary 
outcome in women aged 18–24. However, the direction 
of effect we found for this primary outcome was similar 
to the statistically significant secondary outcome among 
all young people aged 18–30, providing confidence 
that our conclusions likely apply to women aged 18–24 
too. One of the challenges with trials of HIVST is ascer-
taining linkage to care and prevention. We used multiple 
methods to capture linkage events that could be linked 
to the peer navigator pair (cluster) from which they were 
recruited. This protected against inter cluster contami-
nation; however, some linkage events could be missed. 
Moreover, participants may have linked to care outside of 
the surveillance area or may have not been identified by 
the data clerks when attending clinic, and so we may have 
underestimated the linkage to care. This would, however, 
have been likely to affect all arms equally and so should 
not affect the study findings. This was an exploratory 
trial where pairwise comparisons were planned from the 
outset. However, multiple testing can give rise to family- 
wise type 1 error rate that is non- nominal. This needs to 
be considered in interpreting these results. Finally, PrEP 
was a new biomedical intervention in our setting. Expe-
rience from other settings suggests that time is needed 
for a novel biomedical intervention to embed, espe-
cially among young women. In our trial, young men and 
women aged 25–30 accounted for nearly 60% of those 
who linked to PrEP/ART: with longer duration, we may 
have seen demand for PrEP increase among the younger 
women.
CONCLUSION
Our study suggests that although HIVST reached a large 
number of young people, it did not mobilise demand for 
biomedical HIV prevention. Moreover, HIVST in conjunc-
tion with trained peer- led activities to attract and engage 
young people to biomedical HIV prevention performed 
no better than trained peer- led activities alone and was 
more costly. These findings suggest that HIV testing may 
need to be provided alongside trained peer- led activities 
to attract and engage young people into novel biomed-
ical HIV prevention in southern Africa.
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